logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Adalimumab/infliximab/thalidomideDevelopment of antibodies to drug and neuropathy: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2018年 / 1727卷 / 1期
关键词:
D O I:
10.1007/s40278-018-54003-0
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:18 / 18
相关论文
共 50 条
  • [1] InfliximabDeveloped anti-drug antibodies to infliximab: case report
    Reactions Weekly, 2018, 1714 (1) : 227 - 227
  • [2] Adalimumab/infliximab/mesalazineLack of efficacy: case report
    Reactions Weekly, 2023, 1981 (1) : 18 - 18
  • [3] Adalimumab/infliximab/vedolizumabRecurrent pericarditis: case report
    Reactions Weekly, 2020, 1822 (1) : 21 - 21
  • [4] Adalimumab/infliximab/vedolizumabLack of efficacy: case report
    Reactions Weekly, 2020, 1823 (1) : 23 - 23
  • [5] Adalimumab/Infliximab/VedolizumabLack of efficacy: case report
    Reactions Weekly, 2025, 2040 (1) : 32 - 32
  • [6] Adalimumab/infliximab/sulfasalazineTreatment failure: case report
    Reactions Weekly, 2024, 2039 (1) : 21 - 21
  • [7] Adalimumab/infliximab/methotrexateVarious toxicities: case report
    Reactions Weekly, 2023, 1943 (1) : 24 - 24
  • [8] Adalimumab/infliximab/methotrexateNo therapeutic response: case report
    Reactions Weekly, 2022, 1887 (1) : 24 - 24
  • [9] Adalimumab/infliximabSmall fiber neuropathy: case report
    Reactions Weekly, 2018, 1709 (1) : 19 - 19
  • [10] Adalimumab/infliximab/vedolizumabGuillain Barre syndrome: case report
    Reactions Weekly, 2022, 1896 (1) : 21 - 21
← 12345 →